Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study

Lancet Oncology

Volumn 8, Issue 4, 2007, Pages 311-316

  Edgren, Gustaf ^a   Sparén, Pär ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANUS CANCER; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONDYLOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENITAL TRACT CANCER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; RISK ASSESSMENT; SMOKING; SOCIAL STATUS; SWEDEN; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CANCER; VULVA CANCER;

ADOLESCENT; ADULT; AGE FACTORS; ANUS NEOPLASMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS; SWEDEN; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33947522445     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70043-8     Document Type: Article

References (32)

1. Melbye M., and Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 338 (1991) 657-659
2. Bjorge T., Hennig E., Skare G., et al. Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970-1992. Int J Cancer 62 (1995) 29-33
3. Frisch M., and Biggar R. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 354 (1999) 1442-1443
4. Hemminki K., Dong C., and Vaittinen P. Second primary cancer after in situ and invasive cervical cancer. Epidemiology 11 (2000) 457-461
5. Kalliala I., Anttila A., Pukkala E., and Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 331 (2005) 1183-1185
6. Frisch M., Glimelius B., van den Brule A., et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337 (1997) 1350-1358
7. Daling J., Madeleine M., Johnson L., et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101 (2004) 270-280
8. Nuovo G., Delvenne P., MacConnell P., et al. Correlation of histology and detection of human papillomavirus DNA in vulvar cancers. Gynecol Oncol 43 (1991) 275-280
9. Trimble C., Hildesheim A., Brinton L., et al. Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 87 (1996) 59-64
10. WHO International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 64: human papillomaviruses (1995), International Agency for Research on Cancer, Lyon
11. Daling J., Madeleine M., Schwartz S., et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84 (2002) 263-270
12. Koutsky L., Holmes K., Critchlow C., et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327 (1992) 1272-1278
13. Melbye M., Rabkin C., Frisch M., and Biggar R. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 139 (1994) 772-780
14. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
15. Judson P., Habermann E., Baxter N., et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107 (2006) 1018-1022
16. Creasman W. Vaginal cancers. Curr Opin Obstet Gynecol 17 (2005) 71-76
17. Goedert J., Cote T., Virgo P., et al. Spectrum of AIDS-associated malignant disorders. Lancet 351 (1998) 1833-1839
18. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin 53 (2003) 5-26
19. Chin-Hong P., Vittinghoff E., Cranston R., et al. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 97 (2005) 896-905
20. Steinbrook R. The potential of human papillomavirus vaccines. N Engl J Med 354 (2006) 1109-1112
21. Koutsky L., Ault K., Wheeler C., et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347 (2002) 1645-1651
22. Harper D., Franco E., Wheeler C., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364 (2004) 1757-1765
23. Villa L., Costa R., Petta C., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 (2005) 271-278
24. Walboomers J., Jacobs M., Manos M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
25. Swedish National Board of Health and Welfare. Cancer incidence in sweden 2004 (2005), National Board of Health and Welfare, Centre for Epidemiology, Stockholm. http://www.socialstyrelsen.se/Statistik/statistik_amne/Cancer (accessed Jan 30, 2007).
26. Mattsson B., and Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23 (1984) 305-313
27. Ylitalo N., Sorensen P., Josefsson A., et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2194-2198
28. Ylitalo N., Josefsson A., Melbye M., et al. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 60 (2000) 6027-6032
29. Ho G., Bierman R., Beardsley L., et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338 (1998) 423-428
30. van der Avoort I., Shirango H., Hoevenaars B., et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 25 (2006) 22-29
31. George L., Granath F., Johansson A., and Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand 85 (2006) 1331-1337
32. Daling J., Sherman K., Hislop T., et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135 (1992) 180-189